Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive
Mbathio Dieng1,2, Sarah J Lord3, Omgo E Nieweg4,5
1NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, Australia. mbathio.dieng@sydney.edu.au.
Annals of Surgical Oncology
|May 3, 2021
Abstract
No abstract available in PubMed .


